Paris Regional Medical Center offering monoclonal antibody treatment for Covid-19 patients | Free

Paris Regional Medical Center announced today that it is offering both bamlanivimab/casirivimab and imdevimab, new monoclonal antibody therapies, for treatment of non-hospitalized patients with a mild or moderate case of Covid-19. Developed by pharmaceutical companies Eli Lilly/Regeneron Pharmaceuticals Inc., the drug recently received emergency use authorization from the Food and […]